Interactions of the Dipeptide Ester Prodrugs of Acyclovir with the Intestinal Oligopeptide Transporter: Competitive Inhibition of Glycylsarcosine Transport in Human Intestinal Cell Line-Caco-2

10.1007/s002329900177

10.1517/14712598.2.6.607

Anand BS, Nashed YE, and Mitra AK (2002b) Novel dipeptide prodrugs of acyclovir for ocular herpes infections: bioreversion, antiviral activity, and transport across rabbit cornea. Curr Eye Res, in press..

10.1023/A:1019806411610

10.1002/(SICI)1521-3773(20000204)39:3<505::AID-ANIE505>3.0.CO;2-B

10.1006/bbrc.1998.9298

Beauchamp, 1992, Amino acid ester prodrugs of acyclovir., Antiviral Chem Chemother, 3, 157, 10.1177/095632029200300305

10.1016/0003-2697(76)90527-3

10.1016/0006-2952(73)90196-2

Dantzig, 1990, Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2., Biochim Biophys Acta, 1027, 211, 10.1016/0005-2736(90)90309-C

de Vrueh, 1998, Transport of l-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2., J Pharmacol Exp Ther, 286, 1166

Easty DL (1985) Clinical Aspects of Ocular Herpes Simplex Virus Infection. (Chicago Year Book Medical Publishers, Chicago).

10.1056/NEJM199710163371601

10.1074/jbc.270.43.25672

Goldmeier, 1988, Psychosocial implications of recurrent genital herpes simplex virus infection., Genitourin Med, 64, 327

Green MT Dunkel E (1985) Herpes Simplex Virus Infections. (Lea & Febiger, Philadelphia, PA).

Guo, 1999, Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line., J Pharmacol Exp Ther, 289, 448

10.1208/ps010419

10.1023/A:1011919319810

10.1023/A:1011945420235

10.1023/A:1018900124257

Hidalgo, 1989, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability., Gastroenterology, 96, 736, 10.1016/0016-5085(89)90897-4

Hughes, 1993, Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2′-esters in rabbit epithelial keratitis., J Ocul Pharmacol, 9, 299, 10.1089/jop.1993.9.299

10.1093/ndt/15.1.11

10.1038/277491a0

10.1016/0022-2836(82)90515-0

Lister, 1997, The influence of luminal pH on transport of neutral and charged dipeptides by rat small intestine, in vitro., Biochim Biophys Acta, 1324, 245, 10.1016/S0005-2736(96)00230-1

Lupia, 1993, Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue., Antimicrob Agents Chemother, 37, 818, 10.1128/AAC.37.4.818

10.1021/jm015556r

10.1007/BF00845272

10.1016/S0168-3659(01)00427-8

Sakaeda, 2001, Conjugation with l-glutamate for in vivo brain drug delivery., J Drug Target, 9, 23, 10.3109/10611860108995630

Sanitato, 1984, Acyclovir in the treatment of herpetic stromal disease., Am J Ophthalmol, 98, 537, 10.1016/0002-9394(84)90237-X

Sawada, 1999, Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2., J Pharmacol Exp Ther, 291, 705

10.1128/AAC.44.1.207-209.2000

Temple, 1996, A model for the kinetics of neutral and anionic dipeptide-proton cotransport by the apical membrane of rat kidney cortex., J Physiol (Lond), 494, 795, 10.1113/jphysiol.1996.sp021533

10.1038/clpt.1993.196